Karuna Therapeutics
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
N/AN/AN/AN/A
Price/Sales ratio
N/AN/AN/AN/A
Earnings per Share (EPS)
$-8.22$0.65$12.70$28.54

Historical Multiples (2017 – 2023)

2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-24.63-12.42-20.09-39.19-26.54-22.49-26.97-22.62-30.90
Price/Sales ratio
N/AN/AN/AN/A103.26584.2917.88K587.69293.84
Price/Book Value ratio
-11.112.372.317.927.605.519.325.557.76
Price/Cash Flow ratio
-36.89-14.14-29.13-38.45-37.83-27.25-30.31-27.41-33.79
Price/Free Cash Flow ratio
-36.77-14.02-29.02-38.23-36.72-27.14-30.09-27.30-33.62
Price/Earnings Growth ratio
N/A-0.12-0.151.26-0.29-0.29-0.780.270.77
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/A98.63%89.54%-160.09%N/A49.31%
Operating Profit Margin
N/AN/AN/AN/A-389.17%-2723.28%-75653.97%-2723.28%-194.58%
Pretax Profit Margin
N/AN/AN/AN/A-389.02%-2584.54%-66209.48%-2584.54%-194.51%
Net Profit Margin
N/AN/AN/AN/A-389.04%-2597.87%-66311.92%-2597.87%-194.52%
Effective Tax Rate
-19.41%2.39%-2.01%-0.06%-0.00%-0.51%-0.15%-0.51%-0.03%
Return on Assets
-283.32%-18.93%-11.41%-19.72%-27.25%-23.75%-32.45%-23.75%-23.48%
Return On Equity
45.12%-19.12%-11.50%-20.22%-28.64%-24.53%-34.57%-34.87%-24.43%
Return on Capital Employed
51.22%-15.82%-11.64%-21.07%-28.34%-25.64%-39.01%-25.64%-24.71%
Liquidity Ratios
Current Ratio
N/AN/A132.7650.28N/AN/AN/A34.0125.14
Quick Ratio
0.18114.27132.7650.2824.5633.1818.8233.1137.42
Cash ratio
0.16105.9870.637.7410.237.312.727.318.98
Days of Sales Outstanding
N/AN/AN/AN/A17.281.952.73K1.958.64
Days of Inventory outstanding
N/AN/AN/AN/A15.06K9.29K7.04KN/A7.53K
Operating Cycle
N/AN/AN/AN/A15.08K9.29K9.77KN/A7.54K
Days of Payables Outstanding
N/AN/A3.44K2.17K1.39K780.871.45KN/A1.78K
Cash Conversion Cycle
N/AN/AN/AN/A13.68K8.51K8.32KN/A6.84K
Debt Ratios
Debt Ratio
5.470.000.000.000.010.000.010.030.00
Debt Equity Ratio
-0.870.000.000.000.010.000.010.030.00
Long-term Debt to Capitalization
-0.420.000.000.000.010.000.010.000.00
Total Debt to Capitalization
-6.820.000.000.000.010.000.010.000.01
Interest Coverage Ratio
N/AN/A-48.04N/AN/AN/AN/A-20.43N/A
Cash Flow to Debt Ratio
-0.34-150.75-148.66-26.01-13.44-42.79-23.11-42.79-19.73
Company Equity Multiplier
-0.151.001.001.021.051.031.061.031.01
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/A-2.72-21.43-589.93-21.43-1.36
Free Cash Flow / Operating Cash Flow Ratio
1.001.001.001.001.031.001.001.001.01
Cash Flow Coverage Ratio
-0.34-150.75-148.66-26.01-13.44-42.79-23.11-42.79-19.73
Short Term Coverage Ratio
-0.52N/A-533.15-82.76-46.38-99.91-135.70-99.91-64.57
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A